Evaluation of malignant glioma patients during the postirradiation period

View More View Less
  • 1 Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco, California
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

✓ The syndrome of increased focal or generalized central nervous system (CNS) dysfunction in the early postirradiation period in patients treated with radiation therapy (RT) for malignant gliomas has not been well documented. The authors have undertaken retrospective study of 51 patients with supratentorial malignant gliomas who survived longer than 26 weeks from the time of diagnosis. All patients received irradiation and chemotherapy and were evaluated at 8-week intervals. Each evaluation consisted of a neurological examination, computerized tomography (CT) and radionuclide scans, Karnofsky rating, and an evaluation of glucocorticoid levels needed to maintain neurological function. In all, 263 evaluable periods, consisting of 1290 individual evaluable tests (parameters), were analyzed. In the first 18 weeks after RT, 26 of the 51 patients studied (51%) showed deterioration in one or more tests; 14 of the 26 (53%) did not improve. These 14 patients had a median time to tumor progression (MTP) of 31 weeks. The remaining 12 patients in this group (47%) improved and had an MTP of 73 weeks. Of the 51 patients, 25 (49%) showed deterioration significant enough to presume tumor progression (two of the following three tests were unequivocally worse: neurological examination, CT scan, and radionuclide scan), seven improved with no change in therapy and had an MTP of 66 weeks, while the other 18 had an MTP of 32 weeks. Excluding the Karnofsky rating, any individual test that showed worsening during the first 18-week period had a 33% probability of significant improvement at a subsequent evaluation period. After 18 weeks the probability of the test improving was only 4%.

The authors conclude that CNS decompensation up to 18 weeks after RT, as ascertained from clinical examination, scans, or glucocorticoid dosage, does not invariably predict tumor progression, because in 28% (7/25) of such cases there will be subsequent improvement.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address reprint requests to: Victor A. Levin, M.D., Brain Tumor Research Center, University of California, San Francisco, California 94143.
  • 1.

    Arnold A, , Bailey P, & Laughlin JS: Effects of betatron radiation on the brain of primates. Neurology 4:165178, 1954 Arnold A, Bailey P, Laughlin JS: Effects of betatron radiation on the brain of primates. Neurology 4:165–178, 1954

    • Search Google Scholar
    • Export Citation
  • 2.

    Bailey OT: Basic problems in the histopathology of radiation of the central nervous system, in Haley TJ, & Snider RS (eds): Response of the Nervous System to Ionizing Radiation. New York: Academic Press, 1962, pp 165190 Bailey OT: Basic problems in the histopathology of radiation of the central nervous system, in Haley TJ, Snider RS (eds): Response of the Nervous System to Ionizing Radiation. New York: Academic Press, 1962, pp 165–190

    • Search Google Scholar
    • Export Citation
  • 3.

    Boldrey E, & Sheline G: Delayed transitory clinical manifestations after radiation treatment of intracranial tumors. Acta Radiol (Ther) 5:510, 1966 Boldrey E, Sheline G: Delayed transitory clinical manifestations after radiation treatment of intracranial tumors. Acta Radiol (Ther) 5:5–10, 1966

    • Search Google Scholar
    • Export Citation
  • 4.

    Davis L, , Martin J, & Goldman SL, et al: A study of 211 patients with verified glioblastoma multiforme. J Neurosurg 6:3344, 1949 Davis L, Martin J, Goldman SL, et al: A study of 211 patients with verified glioblastoma multiforme. J Neurosurg 6:33–44, 1949

    • Search Google Scholar
    • Export Citation
  • 5.

    Frankel SA, & German WJ: Glioblastoma multiforme. Review of 219 cases with regard to natural history, pathology, diagnostic methods, and treatment. J Neurosurg 15:489503, 1958 Frankel SA, German WJ: Glioblastoma multiforme. Review of 219 cases with regard to natural history, pathology, diagnostic methods, and treatment. J Neurosurg 15:489–503, 1958

    • Search Google Scholar
    • Export Citation
  • 6.

    Freeman JE, , Johnston PGB, & Voke JM: Somnolence after prophylactic cranial irradiation in children with acute lymphoblastic leukaemia. Br Med J 4:523525, 1973 Freeman JE, Johnston PGB, Voke JM: Somnolence after prophylactic cranial irradiation in children with acute lymphoblastic leukaemia. Br Med J 4:523–525, 1973

    • Search Google Scholar
    • Export Citation
  • 7.

    Gehan EA: A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52:203223, 1965 Gehan EA: A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52:203–223, 1965

    • Search Google Scholar
    • Export Citation
  • 8.

    Innes JRM, & Carsten A: Demyelinating or malacic myelopathy. Arch Neurol 4:190199, 1961 Innes JRM, Carsten A: Demyelinating or malacic myelopathy. Arch Neurol 4:190–199, 1961

    • Search Google Scholar
    • Export Citation
  • 9.

    Jones A: Transient radiation myelopathy. (With reference to Lhermitte's sign of electrical paraesthesia). Br J Radiol 37:727744, 1964 Jones A: Transient radiation myelopathy. (With reference to Lhermitte's sign of electrical paraesthesia). Br J Radiol 37:727–744, 1964

    • Search Google Scholar
    • Export Citation
  • 10.

    Lampert PW, & Davis RL: Delayed effects of radiation on the human central nervous system. “Early” and “late” delayed reactions. Neurology 14:912917, 1964 Lampert PW, Davis RL: Delayed effects of radiation on the human central nervous system. “Early” and “late” delayed reactions. Neurology 14:912–917, 1964

    • Search Google Scholar
    • Export Citation
  • 11.

    Levin VA, , Crafts DC, & Norman DM, et al: Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. J Neurosurg 47:329335, 1977 Levin VA, Crafts DC, Norman DM, et al: Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. J Neurosurg 47:329–335, 1977

    • Search Google Scholar
    • Export Citation
  • 12.

    Norton WT: Myelin, in Albers RW, , Siegel GJ, & Katzman R, et al (eds): Basic Neurochemistry. Boston: Little, Brown and Co, 1972, pp 365384 Norton WT: Myelin, in Albers RW, Siegel GJ, Katzman R, et al (eds): Basic Neurochemistry. Boston: Little, Brown and Co, 1972, pp 365–384

    • Search Google Scholar
    • Export Citation
  • 13.

    Rider WD: Radiation damage to the brain — a new syndrome. J Canad Assoc Radiol 14:6769, 1963 Rider WD: Radiation damage to the brain — a new syndrome. J Canad Assoc Radiol 14:67–69, 1963

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 209 103 6
Full Text Views 237 12 0
PDF Downloads 127 9 1
EPUB Downloads 0 0 0